Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych VivasIntellectual disability psychiatry — neurodevelopmental dual diagnosis

Psych Vivas · Intellectual disability psychiatry — neurodevelopmental dual diagnosis

Autism and intellectual disability dual diagnosis — structured clinical viva

Fellowship viva on autism–ID dual diagnosis: criteria logic, AAC, epilepsy, PBS, and selective pharmacotherapy with population-specific evidence.

clinical1 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the dual-diagnosis / ID psychiatry registrar. A multidisciplinary meeting discusses a 12-year-old with moderate ID, suspected ASD, limited speech, weekly self-injury, and possible absence seizures. The paediatrician asks: (1) Can he have both ASD and ID? (2) How do you assess dual diagnosis and communication? (3) How does epilepsy change risk and workup? (4) What is the stepped plan for challenging behaviour, including when medicines are justified? Cover relative developmental rule, AAC, epilepsy gradient, PBS, RUPP/Owen dosing-monitoring, and Tyrer 2008.

Interpretation

Reveal interpretationShowHide

Can he have both? Yes. Dual coding of ASD and ID is allowed when both criteria are met. The hinge is that social communication is below that expected for developmental level, with RRBs and early onset — not IQ alone and not automatic dual labels.[1][2]

Assessment and communication. Developmental history, adaptive and cognitive assessment, multi-setting social-communication observation relative to mental age, RRB/sensory profile, collateral, structured tools as aids. Communication: audiology pathway, speech-language input, total communication, AAC immediately if speech is limited. Genetics after ASD diagnosis when indicated (microarray, fragile X).[1][2]

Epilepsy. Co-occurrence of epilepsy and autism is common and higher with ID. Possible absences need seizure history, neurology liaison, EEG when indicated; behaviour may be peri-ictal. Do not treat all stereotypy as seizure.[3]

Challenging behaviour stepped plan. Safety → medical pain screen → functional analysis/PBS → communication/AAC and environmental supports → treat epilepsy/mental health comorbidities → only then consider risperidone (RUPP: low start ~0.25–0.5 mg/day weight-based, metabolic/EPS/prolactin monitoring) or aripiprazole (Owen: often 2 mg start; metabolic/akathisia monitoring) for severe irritability. Name Tyrer 2008: antipsychotics not superior to placebo for aggression in adults with ID — population-specific prescribing.[4][5][6][7]

Name evidence. Hyman; Thurm; Lukmanji; McCracken RUPP; Owen; Tyrer; Emerson.[1][2][3][4][5][6][7]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Hyman SL, Levy SE, Myers SM Identification, Evaluation, and Management of Children With Autism Spectrum Disorder Pediatrics, 2020.PMID 31843864
  2. [2]Thurm A, Farmer C, Salzman E, Lord C, Bishop S State of the Field: Differentiating Intellectual Disability From Autism Spectrum Disorder Front Psychiatry, 2019.PMID 31417436
  3. [3]Lukmanji S, et al. The co-occurrence of epilepsy and autism: A systematic review Epilepsy Behav, 2019.PMID 31398688
  4. [4]McCracken JT, et al. Risperidone in children with autism and serious behavioral problems N Engl J Med, 2002.PMID 12151468
  5. [5]Owen R, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder Pediatrics, 2009.PMID 19948625
  6. [6]Tyrer P, et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability Lancet, 2008.PMID 18177776
  7. [7]Emerson E, et al. The prevalence of challenging behaviors: a total population study Res Dev Disabil, 2001.PMID 11263632
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAugmentation strategies — consultant vivaPsychopharmacology — augmentation in mood and psychosisNextAutoimmune encephalitis and organic psychosis — structured clinical vivaConsultation-liaison psychiatry